Comparison
Abducens Nerve Neoplasm C1263898 vs 17p11 2 Microduplication Syndrome C2931246
Clinical comparison between Abducens Nerve Neoplasm and 17p11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
Abducens Nerve Neoplasm C1263898
A tumor of the 6th cranial nerve that controls eye movement. Can affect anyone. Treated with surgery or radiation.
17p11 2 Microduplication Syndrome C2931246
A chromosomal condition involving duplication on chromosome 17, related to Potocki-Lupski syndrome. Features often include developmental delays, learning challenges, and distinctive facial features.
6 comparison axes
Onset
Abducens Nerve Neoplasm C1263898
Variable
17p11 2 Microduplication Syndrome C2931246
0-null
Onset patterns differ
Severity
Abducens Nerve Neoplasm C1263898
severe
17p11 2 Microduplication Syndrome C2931246
moderate
Different severity levels
Chronic
Abducens Nerve Neoplasm C1263898
Chronic
17p11 2 Microduplication Syndrome C2931246
Chronic
Differing course
Communicable
Abducens Nerve Neoplasm C1263898
No
17p11 2 Microduplication Syndrome C2931246
No
Different transmission
Body System
Abducens Nerve Neoplasm C1263898
neurologic
17p11 2 Microduplication Syndrome C2931246
congenital
Same/different system
Category
Abducens Nerve Neoplasm C1263898
oncology
17p11 2 Microduplication Syndrome C2931246
genetic
Different category
Bottom line
abducens-nerve-neoplasm-C1263898 and 17p11-2-microduplication-syndrome-C2931246 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Abducens Nerve Neoplasm C1263898 | 17p11 2 Microduplication Syndrome C2931246 | Discriminating power |
|---|---|---|---|
| Eye movement | May cause impaired outward gaze, double vision, or inward eye deviation. | Eye-movement abnormality is not an established core feature from the supplied data. | High |
| Development | Developmental delay is not expected from an isolated nerve tumor. | Often associated with developmental delay and learning challenges. | High |
| Onset | Onset is variable and may be acquired. | Present from conception, with features often recognized in early development. | Moderate |
When to favor each condition
Choose Abducens Nerve Neoplasm C1263898 when
New or progressive double vision
Suggests an acquired neurologic or orbital process requiring targeted assessment.
Moderate
Isolated abduction deficit
Points toward sixth-nerve dysfunction rather than a multisystem genetic syndrome.
Moderate
Imaging concern for a nerve lesion
A suspected tumor requires specialist confirmation; imaging alone may not define histology.
High
Choose 17p11 2 Microduplication Syndrome C2931246 when
Early developmental delay
Supports consideration of a congenital genetic condition when other features fit.
Moderate
Learning challenges with suggestive features
The supplied description links these findings to 17p11.2 duplication.
Moderate
Known chromosomal duplication
Genetic confirmation distinguishes it from an acquired cranial-nerve neoplasm.
High
How key tests differ
| Test | Abducens Nerve Neoplasm C1263898 | 17p11 2 Microduplication Syndrome C2931246 | Interpretation |
|---|---|---|---|
| Brain and orbital MRI | May localize a lesion involving the sixth nerve; histology is not established by imaging alone. | No specific tumor pattern is established by the supplied data. | Abnormal imaging is a finding, not automatically a tumor diagnosis. |
| Chromosomal microarray | Not the primary test for a suspected nerve neoplasm. | Can identify a 17p11.2 duplication when clinically indicated. | Genetic confirmation should be interpreted by a qualified clinician. |
| Neuro-ophthalmic examination | May document limited abduction or misalignment. | Findings are not specifically established here and may be unrelated. | Exam abnormalities require correlation with history and testing. |
Prognosis comparison
Abducens Nerve Neoplasm C1263898
- Outcome
- Outcome is not established and depends on tumor characteristics and response to care.
- Factors
- Lesion location, size, histology, and treatment tolerance may matter.
17p11 2 Microduplication Syndrome C2931246
- Outcome
- Usually a lifelong condition with variable developmental and learning outcomes.
- Factors
- Specific duplication, associated findings, therapies, and support influence function.
Time frame: The tumor course is variable; the genetic condition is lifelong.
No reliable mortality or recovery estimate is supported by the supplied data.
Complications comparison
| Complication | Presentation |
|---|---|
| Visual function | Persistent double vision or misalignment may occur. A characteristic visual complication is not established. Impact varies and needs individual assessment. |
| Neurologic course | Mass effect or nerve dysfunction may progress, but exact risk is not established. Developmental and learning difficulties may be ongoing. Neither course can be predicted from these sparse data. |
| Treatment-related effects | Surgery or radiation may be considered; specific harms and doses are not supplied. Management is generally supportive and individualized. Treatment decisions require specialist judgment. |
Patient education highlights
- HighDifferent conditions
A nerve tumor and a chromosomal duplication have different causes and evaluations.
- HighUrgent eye symptoms
New double vision, eye misalignment, headache, or neurologic change needs prompt clinical assessment.
- MediumGenetic counseling
Confirmed or suspected 17p11.2 duplication may warrant genetics consultation and family discussion.